DermTech Gets CLIA Certification, Validates Melanoma Test | GenomeWeb

NEW YORK (GenomeWeb News) — DermTech International said today that it has completed California CLIA licensure of its San Diego laboratory facility.

The company also said that it has completed validation testing of its proprietary Pigmented Lesion Assay (PLA), which it plans to offer as a laboratory-developed test out of its CLIA lab.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.